Cost-effectiveness of dutasteride is too low for preventive use - ONA

Links shared publicly online about this topic.

  • 507
    total visits

Cost-effectiveness of dutasteride is too low for preventive use - ONA

oncologynurseadvisor.com

Dutasteride may be a cost-effective means of preventing prostate cancer (PCa) only in men at very high risk of the disease, as opposed to all men at elevated risk, according to a recent analysis.

View full resource at oncologynurseadvisor.com

Tags: Cancer, Prostate Cancer, Prostate, Benign Prostatic Hypertrophy Medication, Men's Health, Avodart, Preventing

  • Share

Most Recently Shared on February 14, 2011 at 3:22 pm By:

ONAcom OncologyNurseAdvisor

Cost-effectiveness of dutasteride is too low for preventive use http://goo.gl/fb/HKlav

1 year ago...

Advertisement